Serum-derived nanoparticles: De novo generation and growth in vitro, and internalization by mammalian cells in culture

Nanomedicine

Volumn 6, Issue 4, 2011, Pages 643-658

  Peng, Hsin Hsin ^a   Martel, Jan ^a   Lee, Yu Hsiu ^a   Ojcius, David M ^a,b   Young, John D ^a,c,d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d MING CHI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

biological fluids; biomineralization; calcium carbonate phosphate; cell culture; endocytosis; mineraloprotein complexes; nanoparticles; nanopathology; nanotoxicology; serum

Indexed keywords

CALCIUM CARBONATE; CALCIUM CARBONATE PHOSPHATE; CRYSTALLIN; NANOPARTICLE; PHOSPHATE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CRYSTALLIZATION; CULTURE MEDIUM; DYNAMIC LIGHT SCATTERING; ELECTRON MICROSCOPY; GROWTH; HUMAN; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; LYSOSOME; MATURATION; NORMAL HUMAN; PARTICLE SIZE; PHOTOGRAPHY; PLATE PHOTOGRAPHY; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; SERUM; SPECTROPHOTOMETRY; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY; X RAY DIFFRACTION;

ANIMALS; CALCIUM CARBONATE; CELL LINE; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; SPECTROMETRY, X-RAY EMISSION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 79959986709     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.24     Document Type: Article

References (61)

1. Nel A, Xia T, Madler L, Li N: Toxic potential of materials at the nanolevel. Science 311(5761), 622-627 (2006). (Pubitemid 43191298)
2. Shvedova AA, Kagan VE, Fadeel B: Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu. Rev. Pharmacol. Toxicol. 50, 63-88 (2010).
3. Donaldson K, Murphy FA, Duffin R, Poland CA: Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part. Fibre Toxicol. 7, 5 (2010).
4. Chen HW, Su SF, Chien CT, et al.: Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J. 20(13), 2393-2395 (2006).
5. Kajander EO, Ciftcioglu N: Nanobacteria: an alternative mechanism for pathogenic intra-and extracellular calcification and stone formation. Proc. Natl Acad. Sci. USA 95(14), 8274-8279 (1998). (Pubitemid 28326103)
6. Ciftcioglu N, Bjorklund M, Kuorikoski K, Bergstrom K, Kajander EO: Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 56(5), 1893-1898 (1999). (Pubitemid 29518191)
7. Ciftcioglu N, McKay DS, Mathew G, Kajander EO: Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. J. Investig. Med. 54(7), 385-394 (2006). (Pubitemid 46123033)
8. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ: An alternative interpretation of nanobacteria-induced biomineralization. Proc. Natl Acad. Sci. USA 97(21), 11511-11515 (2000).
9. Raoult D, Drancourt M, Azza S, et al.: Nanobacteria are mineralo fetuin complexes. PLoS Pathog. 4(2), e41 (2008).
10. Martel J, Young JD: Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc. Natl Acad. Sci. USA 105(14), 5549-5554 (2008). (Pubitemid 351753900)
11. Young JD, Martel J, Young L, Wu CY, Young A, Young D: Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS ONE 4(2), e4417 (2009).
12. Young JD, Martel J, Young D, et al.: Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS ONE 4(5), e5421 (2009).
13. Wu CY, Martel J, Young D, Young JD: Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept. PLoS ONE 4(11), e8058 (2009).
14. Martel J, Wu CY, Young JD: Critical evaluation of g-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles. PLoS ONE 5(4), e10343 (2010).
15. Young JD, Martel J: The rise and fall of nanobacteria. Sci. Am. 302(1), 52-59 (2010).
16. Evan AP, Coe FL, Rittling SR, et al.: Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 68(1), 145-154 (2005). (Pubitemid 43181371)
17. Gatti AM, Montanari S: Clinical cases: lung, blood, liver, kidney, digestive system, vessels, sperm. In: Nanopathology. The Health Impact of Nanoparticles. Pan Stanford Publishing Pte. Ltd, Singapore 39-133 (2008).
18. Schlieper G, Aretz A, Verberckmoes SC, et al.: Ultrastructural analysis of vascular calcifications in uremia. J. Am. Soc. Nephrol. 21(4), 689-696 (2010).
19. Price PA, Caputo JM, Williamson MK: Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. J. Bone Miner. Res. 17(7), 1171-1179 (2002). (Pubitemid 34680493)
20. Price PA, Nguyen TM, Williamson MK: Biochemical characterization of the serum fetuin-mineral complex. J. Biol. Chem. 278(24), 22153-22160 (2003). (Pubitemid 36792626)
21. Matsui I, Hamano T, Mikami S, et al.: Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int. 75(9), 915-928 (2009).
22. Precipitates in serum products. Perbio Science HyClone News 11(November), (2005).
23. Pedraza CE, Chien YC, McKee MD: Calcium oxalate crystals in fetal bovine serum: implications for cell culture, phagocytosis and biomineralization studies in vitro. J. Cell Biochem. 103(5), 1379-1393 (2008). (Pubitemid 351490708)
24. Tse SM, Furuya W, Gold E, et al.: Differential role of actin, clathrin, and dynamin in Fc gamma receptor-mediated endocytosis and phagocytosis. J. Biol. Chem. 278(5), 3331-3338 (2003). (Pubitemid 36801247)
25. Gaucher G, Asahina K, Wang J, Leroux JC: Effect of poly(N-vinyl- pyrrolidone)-block-poly(d,l-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. Biomacromolecules 10(2), 408-416 (2009).
26. DOro U, Vacchio MS, Weissman AM, Ashwell JD: Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation. Immunity 7(5), 619-628 (1997). (Pubitemid 28156630)
27. Crotzer VL, Mabardy AS, Weiss A, Brodsky FM: T cell receptor engagement leads to phosphorylation of clathrin heavy chain during receptor internalization. J. Exp. Med. 199(7), 981-991 (2004). (Pubitemid 38481089)
28. Hochella MF Jr, Lower SK, Maurice PA, et al.: Nanominerals, mineral nanoparticles, and earth systems. Science 319(5870), 1631-1635 (2008). (Pubitemid 351432492)
29. Anderle G, Mendelsohn R: Thermal denaturation of globular proteins. fourier transform-infrared studies of the amide III spectral region. Biophys. J. 52(1), 69-74 (1987).
30. Kahrim K, Daveri A, Rocchi P, et al.: The application of in situ mid-FTIR fibre-optic reflectance spectroscopy and GC-MS analysis to monitor and evaluate painting cleaning. Spectrochim. Acta A Mol. Biomol. Spectrosc. 74(5), 1182-1188 (2009).
31. Watari F, Takashi N, Yokoyama A, et al.: Material nanosizing effect on living organisms: non-specific, biointeractive, physical size effects. J. R. Soc. Interface 6(Suppl. 3), S371-S388 (2009).
32. Anderson HC, Garimella R, Tague SE: The role of matrix vesicles in growth plate development and biomineralization. Front. Biosci. 10, 822-837 (2005).
33. Reynolds JL, Skepper JN, McNair R, et al.: Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification. J. Am. Soc. Nephrol. 16(10), 2920-2930 (2005). (Pubitemid 44743490)
34. Thode K, Luck M, Semmler W, Muller RH, Kresse M: Determination of plasma protein adsorption on magnetic iron oxides: sample preparation. Pharm. Res. 14(7), 905-910 (1997). (Pubitemid 27326986)
35. Goppert TM, Muller RH: Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). Eur. J. Pharm. Biopharm. 60(3), 361-372 (2005). (Pubitemid 40922833)
36. Kim HR, Andrieux K, Delomenie C, et al.: Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and protein lab-on-chip system. Electrophoresis 28(13), 2252-2261 (2007). (Pubitemid 47065153)
37. Dobrovolskaia MA, Patri AK, Zheng J, et al.: Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5(2), 106-117 (2009).
38. Garnett J, Dieppe P: The effects of serum and human albumin on calcium hydroxyapatite crystal growth. Biochem. J. 266(3), 863-868 (1990). (Pubitemid 20103723)
39. Gilman H, Hukins DW: Seeded growth of hydroxyapatite in the presence of dissolved albumin. J. Inorg. Biochem. 55(1), 21-30 (1994). (Pubitemid 24189619)
40. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, Jahnen-Dechent W: The serum protein a2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J. Biol. Chem. 271(34), 20789-20796 (1996). (Pubitemid 26281865)
41. Schafer C, Heiss A, Schwarz A, et al.: The serum protein a 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112(3), 357-366 (2003). (Pubitemid 38063764)
42. Jiang X, Weise S, Hafner M, et al.: Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J. R. Soc. Interface 7(Suppl. 1), S5-S13 (2010).
43. Sahay G, Alakhova DY, Kabanov AV: Endocytosis of nanomedicines. J. Control. Release 145(3), 182-195 (2010).
44. Alwan WH, Dieppe PA, Elson CJ, Bradfield JW: Hydroxyapatite and urate crystal induced cytokine release by macrophages. Ann. Rheum. Dis. 48(6), 476-482 (1989). (Pubitemid 19158935)
45. Cheung HS, Devine TR, Hubbard W: Calcium phosphate particle induction of metalloproteinase and mitogenesis: effect of particle sizes. Osteoarthritis Cartilage 5(3), 145-151 (1997). (Pubitemid 27261989)
46. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P: Intracellular vesicular traffic. In: Molecular Biology of the Cell (4th Edition). Garland Science, NY, USA 711-766 (2002).
47. Rejman J, Oberle V, Zuhorn IS, Hoekstra D: Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377(Pt 1), 159-169 (2004). (Pubitemid 38114443)
48. Kajander EO: Nanobacteria - propagating calcifying nanoparticles. Lett. Appl. Microbiol. 42(6), 549-552 (2006). (Pubitemid 43780566)
49. Ciftcioglu N, Vejdani K, Lee O, et al.: Association between Randalls plaque and calcifying nanoparticles. Int. J. Nanomedicine 3(1), 105-115 (2008). (Pubitemid 351517081)
50. Lieske JC: Can biologic nanoparticles initiate nephrolithiasis? Nat. Clin. Pract. Nephrol. 4(6), 308-309 (2008).
51. Miller VM, Hunter LW, Chu K, et al.: Biologic nanoparticles and platelet reactivity. Nanomedicine 4(7), 725-733 (2009).
52. Schwartz MK, Hunter LW, Huebner M, Lieske JC, Miller VM: Characterization of biofilm formed by human-derived nanoparticles. Nanomedicine (Lond.) 4(8), 931-941 (2009).
53. Kokubo T, Miyaji F, Kim HM: Spontaneous formation of bonelike apatite layer on chemically treated titanium metals. J. Am. Geram. Soc. 79(4), 1127-1129 (1996). (Pubitemid 126553709)
54. Kokubo T: Apatite formation on surfaces of ceramics, metals and polymers in body environment Acta Mater. 46(7), 2519-2527 (1998). (Pubitemid 128395164)
55. Wang CX, Wang M, Zhou X: Electrochemical impedance spectroscopy study of the nucleation and growth of apatite on chemically treated titanium. Langmuir 18, 7641-7647 (2002). (Pubitemid 35383184)
56. Chin WC, Orellana MV, Verdugo P: Spontaneous assembly of marine dissolved organic matter into polymer gels. Nature 391, 568-572 (1998). (Pubitemid 28157594)
57. Jahnen-Dechent W, Schafer C, Ketteler M, McKee MD: Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J. Mol. Med. 86(4), 379-389 (2008).
58. Ghadially FN: As you like it, part 3: a critique and historical review of calcification as seen with the electron microscope. Ultrastruct. Pathol. 25, 243-267 (2001). (Pubitemid 32607297)
59. Evan AP, Coe FL, Lingeman JE, et al.: Mechanism of formation of human calcium oxalate renal stones on Randalls plaque. Anat. Rec. (Hoboken) 290(10), 1315-1323 (2007). (Pubitemid 47573203)
60. Ryall RL: The future of stone research: rummagings in the attic, Randalls plaque, nanobacteria, and lessons from phylogeny. Urol. Res. 36(2), 77-97 (2008).
61. Gemini bio-products. Precipitates in serum. Gemini, West Sacramento, CA, USA www.gembio.com/doc-files/Precipitates%20 in%20Serum.pdf